immatics biotechnologies GmbH
Patents, Design & Utilities

Last updated:

List of all immatics biotechnologies GmbH patents 820 in total

Status Patent
Application
Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST PANCREATIC CANCER AND OTHER CANCERS External link
Filling date: 9 Sep 2025 Issue date: 26 Dec 2019
Application
Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST PANCREATIC CANCER AND OTHER CANCERS External link
Filling date: 9 Sep 2025 Issue date: 26 Dec 2019
Application
Utility: IMMUNOTHERAPY AGAINST MELANOMA AND OTHER CANCERS External link
Filling date: 9 Sep 2025 Issue date: 26 Dec 2019
Grant
Utility: Peptides and combination of peptides and scaffolds thereof for use in immunotherapy against colorectal carcinoma (CRC) and other cancers External link
Filling date: 9 Sep 2025 Issue date: 24 Dec 2019
Grant
Utility: Peptides and combination of peptides for use in immunotherapy against cancers External link
Filling date: 9 Sep 2025 Issue date: 24 Dec 2019
Application
Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST EPITHELIAL OVARIAN CANCER AND OTHER CANCERS External link
Filling date: 9 Sep 2025 Issue date: 19 Dec 2019
Application
Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST PROSTATE CANCER AND OTHER CANCERS External link
Filling date: 9 Sep 2025 Issue date: 12 Dec 2019
Application
Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC AND OTHER CANCERS External link
Filling date: 9 Sep 2025 Issue date: 12 Dec 2019
Grant
Utility: Peptides and combination of peptides for use in immunotherapy against various tumors External link
Filling date: 9 Sep 2025 Issue date: 10 Dec 2019
Grant
Utility: Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers External link
Filling date: 9 Sep 2025 Issue date: 3 Dec 2019
Grant
Utility: Peptides and combination of peptides for use in immunotherapy against breast cancer and other cancers External link
Filling date: 9 Sep 2025 Issue date: 26 Nov 2019
Grant
Utility: Peptides and combination of peptides for use in immunotherapy against esophageal cancer and other cancers External link
Filling date: 9 Sep 2025 Issue date: 26 Nov 2019
Grant
Utility: Immunotherapy against several tumors, such as lung cancer, including NSCLC External link
Filling date: 9 Sep 2025 Issue date: 26 Nov 2019
Grant
Utility: Peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancers External link
Filling date: 9 Sep 2025 Issue date: 26 Nov 2019
Grant
Utility: Peptides and combination of peptides for use in immunotherapy against various tumors External link
Filling date: 9 Sep 2025 Issue date: 26 Nov 2019
Application
Utility: PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST CANCERS External link
Filling date: 9 Sep 2025 Issue date: 21 Nov 2019
Grant
Utility: Immunotherapy against several tumors including gastrointestinal and gastric cancer External link
Filling date: 9 Sep 2025 Issue date: 19 Nov 2019
Grant
Utility: Immunotherapy against several tumors, such as lung cancer, including NSCLC External link
Filling date: 9 Sep 2025 Issue date: 19 Nov 2019
Grant
Utility: Peptides and combination of peptides and scaffolds for use in immunotherapy against renal cell carcinoma (RCC) and other cancers External link
Filling date: 9 Sep 2025 Issue date: 19 Nov 2019
Grant
Utility: Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers External link
Filling date: 9 Sep 2025 Issue date: 19 Nov 2019
Grant
Utility: Peptides and combination of peptides for use in immunotherapy against various tumors External link
Filling date: 9 Sep 2025 Issue date: 19 Nov 2019
Grant
Utility: Peptides, combination of peptides as targets and for use in immunotherapy against gallbladder cancer and cholangiocarcinoma and other cancers External link
Filling date: 9 Sep 2025 Issue date: 12 Nov 2019
Grant
Utility: Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers External link
Filling date: 9 Sep 2025 Issue date: 12 Nov 2019
Grant
Utility: Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers External link
Filling date: 9 Sep 2025 Issue date: 12 Nov 2019
Application
Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC AND OTHER CANCERS External link
Filling date: 9 Sep 2025 Issue date: 7 Nov 2019
Application
Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC AND OTHER CANCERS External link
Filling date: 9 Sep 2025 Issue date: 7 Nov 2019
Application
Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST NHL AND OTHER CANCERS External link
Filling date: 9 Sep 2025 Issue date: 7 Nov 2019
Grant
Utility: Immunotherapy against melanoma and other cancers External link
Filling date: 9 Sep 2025 Issue date: 5 Nov 2019
Grant
Utility: Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers External link
Filling date: 9 Sep 2025 Issue date: 5 Nov 2019
Grant
Utility: Peptides, combination of peptides as targets and for use in immunotherapy against gallbladder cancer and cholangiocarcinoma and other cancers External link
Filling date: 9 Sep 2025 Issue date: 5 Nov 2019
Grant
Utility: Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers External link
Filling date: 9 Sep 2025 Issue date: 5 Nov 2019
Application
Utility: PEPTIDES, COMBINATION OF PEPTIDES, AND CELL BASED MEDICAMENTS FOR USE IN IMMUNOTHERAPY AGAINST URINARY BLADDER CANCER AND OTHER CANCERS External link
Filling date: 9 Sep 2025 Issue date: 31 Oct 2019
Application
Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST BREAST CANCER AND OTHER CANCERS External link
Filling date: 9 Sep 2025 Issue date: 31 Oct 2019
Grant
Utility: Peptides and combination of peptides and scaffolds thereof for use in immunotherapy against colorectal carcinoma (CRC) and other cancers External link
Filling date: 9 Sep 2025 Issue date: 29 Oct 2019
Application
Utility: NOVEL IMMUNOTHERAPY AGAINST NEURONAL AND BRAIN TUMORS External link
Filling date: 9 Sep 2025 Issue date: 24 Oct 2019
Application
Utility: IMMUNOTHERAPY AGAINST MELANOMA AND OTHER CANCERS External link
Filling date: 9 Sep 2025 Issue date: 24 Oct 2019
Application
Utility: IMMUNOTHERAPY AGAINST MELANOMA AND OTHER CANCERS External link
Filling date: 9 Sep 2025 Issue date: 24 Oct 2019
Application
Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST SMALL CELL LUNG CANCER AND OTHER CANCERS External link
Filling date: 9 Sep 2025 Issue date: 24 Oct 2019
Application
Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST SMALL CELL LUNG CANCER AND OTHER CANCERS External link
Filling date: 9 Sep 2025 Issue date: 24 Oct 2019
Application
Utility: NOVEL IMMUNOTHERAPY AGAINST SEVERAL TUMORS INCLUDING GASTROINTESTINAL AND GASTRIC CANCER External link
Filling date: 9 Sep 2025 Issue date: 24 Oct 2019
Application
Utility: IMMUNOTHERAPY AGAINST SEVERAL TUMORS, SUCH AS LUNG CANCER, INCLUDING NSCLC External link
Filling date: 9 Sep 2025 Issue date: 24 Oct 2019
Application
Utility: NOVEL T CELL RECEPTORS AND IMMUNE THERAPY USING THE SAME External link
Filling date: 9 Sep 2025 Issue date: 24 Oct 2019
Grant
Utility: Immunotherapy against several tumors of the blood, in particular chronic lymphoid leukemia (CLL) External link
Filling date: 9 Sep 2025 Issue date: 22 Oct 2019
Grant
Utility: Peptides and combination of peptides and scaffolds for use in immunotherapy against renal cell carcinoma (RCC) and other cancers External link
Filling date: 9 Sep 2025 Issue date: 22 Oct 2019
Grant
Utility: Peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers External link
Filling date: 9 Sep 2025 Issue date: 22 Oct 2019
Grant
Utility: Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers External link
Filling date: 9 Sep 2025 Issue date: 22 Oct 2019
Grant
Utility: Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers External link
Filling date: 9 Sep 2025 Issue date: 22 Oct 2019
Grant
Utility: Peptides and combination of peptides for use in immunotherapy against various tumors External link
Filling date: 9 Sep 2025 Issue date: 22 Oct 2019
Application
Utility: Novel peptides and combination of peptides for use in immunotherapy and methods for generating scaffolds for the use against pancreatic cancer and other cancers External link
Filling date: 9 Sep 2025 Issue date: 17 Oct 2019
Application
Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES AND SCAFFOLDS FOR USE IN IMMUNOTHERAPY AGAINST RENAL CELL CARCINOMA (RCC) AND OTHER CANCERS External link
Filling date: 9 Sep 2025 Issue date: 17 Oct 2019

Showing 700 to 750 of 820 patents.